Baltimore Washington Financial Advisors Inc. Sells 104 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Baltimore Washington Financial Advisors Inc. cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.4% in the third quarter, Holdings Channel reports. The institutional investor owned 7,307 shares of the financial services provider’s stock after selling 104 shares during the period. Baltimore Washington Financial Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $1,064,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF during the third quarter valued at approximately $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF during the third quarter valued at approximately $30,000. Bbjs Financial Advisors LLC acquired a new position in iShares Biotechnology ETF during the second quarter valued at approximately $31,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Finally, Voisard Asset Management Group Inc. acquired a new position in iShares Biotechnology ETF during the third quarter valued at approximately $59,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $137.96 on Friday. The stock has a 50 day moving average price of $143.43 and a 200 day moving average price of $141.81. iShares Biotechnology ETF has a 52 week low of $117.28 and a 52 week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.